Accessible treatment: If we can classify the patients into those who don’t need chemotherapy and those who need chemotherapy, that will save money, says Dr Devanand.
THE biosimilar version of the breast cancer drug trastuzumab was approved by the United States Food and Drug Administration (FDA) in December. Not long after, neighbouring Thailand also registered the drug.
But the Malaysian authorities are dragging their feet in registering the the drug, which could bring some hope to patients who wanted the targeted drug therapy.
Already a subscriber? Log in.
Save 30% and win Bosch appliances! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
